Real-Time Continuous Glucose Monitoring (CGM) for two additional groups of diabetic patients has been included into Dutch basic health insurance package

13

Jun 2017

The Care Institute Netherlands (Zorginstituut Nederland) has released information that real-time continuous glucose monitoring is now included into the basic health insurance package for two additional groups of patients suffered from diabetes:

  • Women with diabetes who wish to become pregnant. It is advised to use this method in preparation for pregnancy. The annual number of target population is about 65 women per year;
  • Patients with type 1 diabetes with repeated severe hypoglycemia (low / fluctuating blood sugar levels). The annual number of target population is about 1,400 patients per year.

The advice for inclusion of real-time continuous glucose monitoring for these two groups of patients has been given within the round table dedicated to diabetic care that was initiated by the Dutch Diabetes Federation and Care Institute Netherlands and was conducted in collaboration with health insurers, industry and the Government. The consortium focused on improving the quality of care and the appropriate use of medicines and devices for the diabetes care.

The next meeting will be on 16th of June 2017 and agenda includes the discussion the application of new glucose meter (Flash Glucose Monitoring) in patients with diabetes in relation to cost-effectiveness.

See press release in Dutch here.

See results of work of the round table for diabetes care here.

Subscribe to our biweekly newsletter not to miss important reimbursement information.

The latest related news

25

Mar 2022

On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

17

Mar 2022

On February 21, 2022, it was announced by the Ministry of Health that the public consultation regarding the Draft Order amending the Common Package of Benefits of the National Health System (SNS) was open. The amendments and clarifications are related to the fields of in-vitro diagnostics, ENT, pulmonary and airways, e-health, neurology, dental care, radiology, and enteral nutrition.

Read more

16

Mar 2022

In February 2022, Swedish Medical Technologies Product (MTP) Council issued an updated recommendation on FreeStyle Libre for continuous glucose monitoring in type 2 diabetes (T2D). The initial recommendations were published by NT Council in 2018 and updated by MTP Council in 2020 to include FreeStyle Libre 2. In the 2022 update, MTP Council decreased the Hba1c limit from 70 to 60 mmol/mol and added a statement on lifestyle changes and treatment optimization with non-insulin antidiabetic drugs.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more